The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Camcevi



Accord Healthcare S.L.U.EU/1/22/1647/001

Main Information

Trade NameCamcevi
Active SubstancesLeuprorelin Mesilate
Leuprorelin
Dosage FormProlonged-release suspension for injection
Licence HolderAccord Healthcare S.L.U.
Licence NumberEU/1/22/1647/001

Group Information

ATC CodeL02AE02 leuprorelin

Status

License statusAuthorised
Licence Issued24/06/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back